![](/img/cover-not-exists.png)
Polatuzumab vedotin: an investigational anti-CD79b antibody drug conjugate for the treatment of diffuse large B-cell lymphoma
Bourbon, Estelle, Salles, GillesJournal:
Expert Opinion on Investigational Drugs
DOI:
10.1080/13543784.2020.1800638
Date:
July, 2020
File:
PDF, 2.17 MB
2020